The article analyzes corporate vectors of chronic disease through internal industry documents to develop counter-strategies. It is published in the New England Journal of Medicine, Volume 394, Number 12, Pages 1231-1237, on March 26, 2026. Corporations act as vectors of disease by prioritizing profits over health through environmental pollution. Since the publication of Rachel Carson's Silent Spring in 1962, governments have been putting in place regulations to protect against harmful chemicals in food, air, and water. These regulations face resistance from the large corporations that profit from them. The Trump administration has rescinded the EPA's 2009 findings on the dangers of greenhouse gases, loosened vehicle emissions standards and weakened pollution controls on power plants and oil operations. Increased exposure today leads to higher rates of cancer, respiratory disease, cardiovascular disease and developmental disabilities in the future. Deregulation allows corporations to spread disease through environmental exposure, which will negatively affect the health of current and future generations.[1]